CSS LLC’s Apellis Pharmaceuticals APLS Stock Holding History

CSS LLC’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,300	Closed	-$1.58M	–	1013
2026 Q1	$1.58M	Buy	+39,300	New	+$847K	0.08%	204
2022 Q4	–	Sell	-6,800	Closed	-$464K	–	948
2022 Q3	$464K	Buy	+6,800	New	+$402K	0.02%	537
2022 Q2	–	Sell	-38,500	Closed	-$1.96M	–	1097
2022 Q1	$1.96M	Buy	+38,500	New	+$1.7M	0.07%	274
2020 Q2	–	Sell	-7,000	Closed	-$188K	–	660
2020 Q1	$188K	Sell	7,000 -1,000	-13%	-$35.5K	0.01%	436
2019 Q4	$245K	Buy	+8,000	New	+$221K	0.01%	477

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CSS LLC's APLS Position: Q2 2026 in Review

CSS LLC sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 42,818 shares — an estimated $1.72M sold.

CSS LLC first reported a position in APLS in Q1 2022 and held it in 2 quarters. The position peaked at $1.72M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

CSS LLC reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
CSS LLC sold 42,818 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.72M.
CSS LLC first reported a position in Apellis Pharmaceuticals in Q1 2022 and held it in 2 quarters.
CSS LLC's Apellis Pharmaceuticals position peaked at $1.72M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.